Shigella bacteria, which causes Shigellosis, is the primary cause of bacterial diarrhea and diarrheal death among juveniles under five years of age. Because of the antibiotic resistance of Shigella strains, no commercial vaccines are available to date.
An article published in Molecular Pharmaceutics presented an extension of a previous work that demonstrated the stabilization of “invasion plasmid antigen C” (IpaC) protein by using Shigella dysenteriae serotype 1 (Sd1)-based recombinant to induce immune responses in BALB/c mice. However, this work involved the administration of three intranasal doses of IpaC without an adjuvant.
The aim of this study was to increase patient compliance by reducing the dosing frequency. Based on previous screening results, the optimal protective dose of stabilized IpaC, 20 micrograms was encapsulated in biodegradable polymeric poly(lactide-co-glycolide) (PLGA) nanoparticles with approximately 370 nanometers in size and a single-dose nanovaccine was administered intranasally into BALB/c mice.
The results revealed a temporal increase in antibody production with improved cytokine response via nanovaccine administration compared to free IpaC, which was administered three times in a previous study. The vaccinated animals were protected from diarrhea, lethargy, and weight loss upon intraperitoneal challenge with a high dose of heterologous Shigella flexneri 2a, whereas all the control animals died within 36 hours after the challenge.
Overall, the created nanovaccine could be investigated as a potential non-invasive, cross-protective, single-dose, single-antigen Shigella vaccine that is scalable and eventually suitable for mass vaccination.
Shigellosis and Development of Nanovaccine
Shigellosis is an intestinal infection caused by Shigella bacteria. Symptoms generally start one to two days after exposure and include diarrhea, fever, abdominal pain, and the need to pass stools, even when the bowels are empty.
Most Shigella strains develop resistance to many antibiotics. Since an approved vaccine is still unavailable, formulating an effective Shigella vaccine candidate has been declared a public health priority by the World Health Organization (WHO).
Nanotechnology plays a unique role in vaccine design by providing them with enhanced specificity and potency. Nanoparticles of less than 500 nanometers are quickly taken up by antigens and hence serve as potential carriers for delivering vaccine antigens and adjuvants. Nanoparticles have advantages, such as improved antigen stability, targeted delivery, and long-term release, for which antigens/adjuvants are either encapsulated within or decorated on the surface of a nanoparticle.
Nanovaccine exhibits unique physicochemical characteristics. The role of a nanovaccine as a potent vaccine has been examined to boost their therapeutic activity by enhancing their stability, prolonging their circulation and site-specific accumulation, increasing their delivery according to various biological and external stimuli, and overcoming physiological barriers.
As an active immunogenic material that modulates the immune response, a nanovaccine enables antigen stability, enhances antigen processing and immunogenicity with targeted delivery, and prevents the burst release of antigens and adjuvants.
IpaC-Based Single Dose Nanovaccine for Shigellosis
Although there has been a great deal of effort to develop a Shigella vaccine that is both safe and effective, none has been clinically approved. Although conserved recombinant subunit vaccines can be cross-protective in nature, adjuvants are required to provide sufficient immunogenicity, which may present safety issues.
Furthermore, the administration of multiple doses of subunit proteins along with adjuvants in previous studies did not result in sufficient immunogenicity and effective cross-protection. Previously, a self-adjuvant vaccine was created by stabilizing IpaC, an unstable conserved recombinant Shigella protein. Three intranasal doses of stabilized Shigella dysenteriae IpaC resulted in 100% survival when challenged with heterologous Shigella flexneri.
The present study was a step toward extending the shelf life of stabilized IpaC and lowering the dose frequency to boost patient compliance. Here, a previously determined minimum protective dose, 20 micrograms of IpaC, was administered intranasally as a single dose nanovaccine, wherein a biodegradable PLGA polymer was used to formulate the nanovaccine.
Additionally, because PLGA shows adjuvant properties owing to the depot effect, it avoids the need for an additional adjuvant. Thus, utilizing PLGA nanoparticles to deliver Shigella proteins helps to develop a minimalist single-antigen nanovaccine against Shigella.
The developed PLGA 50:50 nanoparticles released up to 77% of the encapsulated protein in 28 days at 37 degrees Celsius and were degraded in 35 days under physiological conditions. Following the administration of the nanovaccine, the nanoparticles were lyophilized effectively and transported, which was desirable for translatable vaccines.
Furthermore, IgG and IgA titers increased with time, indicating sustained release of IpaC from the nanovaccine. Ultimately, the single-dose nanovaccine encapsulating 20 micrograms of stabilized IpaC showed potential as a non-invasive, single-antigen nanovaccine against Shigella.
Conclusion
Overall, the present work provided evidence that encapsulating a minimum protective dose of stabilized S. dysenteriae IpaC protein in PLGA 50:50 nanoparticles results in a non-invasive, single-dose, single-antigen, cross-protective Shigella nanovaccine with scope for mass scale-up and immunization.
News
How the FDA opens the door to risky chemicals in America’s food supply
Lining the shelves of American supermarkets are food products with chemicals linked to health concerns. To a great extent, the FDA allows food companies to determine for themselves whether their ingredients and additives are [...]
Superbug crisis could get worse, killing nearly 40 million people by 2050
The number of lives lost around the world due to infections that are resistant to the medications intended to treat them could increase nearly 70% by 2050, a new study projects, further showing the [...]
How Can Nanomaterials Be Programmed for Different Applications?
Nanomaterials are no longer just small—they are becoming smart. Across fields like medicine, electronics, energy, and materials science, researchers are now programming nanomaterials to behave in intentional, responsive ways. These advanced materials are designed [...]
Microplastics Are Invading Our Arteries, and It Could Be Increasing Your Risk of Stroke
Higher levels of micronanoplastics were found in carotid artery plaque, especially in people with stroke symptoms, suggesting a potential new risk factor. People with plaque buildup in the arteries of their neck have been [...]
Gene-editing therapy shows early success in fighting advanced gastrointestinal cancers
Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results, recently published in The Lancet Oncology, show encouraging [...]
Engineered extracellular vesicles facilitate delivery of advanced medicines
Graphic abstract of the development of VEDIC and VFIC systems for high efficiency intracellular protein delivery in vitro and in vivo. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-59377-y. https://www.nature.com/articles/s41467-025-59377-y Researchers at Karolinska Institutet have developed a technique [...]
Brain-computer interface allows paralyzed users to customize their sense of touch
University of Pittsburgh School of Medicine scientists are one step closer to developing a brain-computer interface, or BCI, that allows people with tetraplegia to restore their lost sense of touch. While exploring a digitally [...]
Scientists Flip a Gut Virus “Kill Switch” – Expose a Hidden Threat in Antibiotic Treatment
Scientists have long known that bacteriophages, viruses that infect bacteria, live in our gut, but exactly what they do has remained elusive. Researchers developed a clever mouse model that can temporarily eliminate these phages [...]
Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressing
Background Wound healing is a complex physiological process that can be compromised by infection and impaired tissue regeneration. Conventional dressings, typically made from natural fibers such as cotton or linen, offer limited functionality. Nanofiber [...]
Global Nanomaterial Regulation: A Country-by-Country Comparison
Nanomaterials are materials with at least one dimension smaller than 100 nanometres (about 100,000 times thinner than a human hair). Because of their tiny size, they have unique properties that can be useful in [...]
Pandemic Potential: Scientists Discover 3 Hotspots of Deadly Emerging Disease in the US
Virginia Tech researchers discovered six new rodent carriers of hantavirus and identified U.S. hotspots, highlighting the virus’s adaptability and the impact of climate and ecology on its spread. Hantavirus recently drew public attention following reports [...]
Studies detail high rates of long COVID among healthcare, dental workers
Researchers have estimated approximately 8% of Americas have ever experienced long COVID, or lasting symptoms, following an acute COVID-19 infection. Now two recent international studies suggest that the percentage is much higher among healthcare workers [...]
Melting Arctic Ice May Unleash Ancient Deadly Diseases, Scientists Warn
Melting Arctic ice increases human and animal interactions, raising the risk of infectious disease spread. Researchers urge early intervention and surveillance. Climate change is opening new pathways for the spread of infectious diseases such [...]
Scientists May Have Found a Secret Weapon To Stop Pancreatic Cancer Before It Starts
Researchers at Cold Spring Harbor Laboratory have found that blocking the FGFR2 and EGFR genes can stop early-stage pancreatic cancer from progressing, offering a promising path toward prevention. Pancreatic cancer is expected to become [...]
Breakthrough Drug Restores Vision: Researchers Successfully Reverse Retinal Damage
Blocking the PROX1 protein allowed KAIST researchers to regenerate damaged retinas and restore vision in mice. Vision is one of the most important human senses, yet more than 300 million people around the world are at [...]
Differentiating cancerous and healthy cells through motion analysis
Researchers from Tokyo Metropolitan University have found that the motion of unlabeled cells can be used to tell whether they are cancerous or healthy. They observed malignant fibrosarcoma [...]
